Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Piramal Group to infuse Rs 500 crore in pharma operations in Telangana

      Piramal Group to infuse Rs 500 crore in pharma operations in Telangana

      Medical Dialogues Bureau23 Jan 2020 10:15 AM IST
      Hyderabad: Healthcare major Piramal Group has agreed to invest Rs 500 crore over the next three years in Telangana for setting up new facilities and...
      Japanese financial group MUFG sells 2.10pc shares in Cipla

      Japanese financial group MUFG sells 2.10pc shares in Cipla

      Medical Dialogues Bureau23 Jan 2020 10:00 AM IST
      "MUFG has sold an indirect interest in Cipla Ltd on account of sale of the following entities: First State Investment Management (UK) Ltd, First...
      Lupin Foundation Wins IDMA Corporate Citizen Award 2019

      Lupin Foundation Wins IDMA Corporate Citizen Award 2019

      Medical Dialogues Bureau23 Jan 2020 9:45 AM IST
      Mumbai: Pharma major Lupin Limited (Lupin) recently announced that its corporate social responsibility (CSR) arm, Lupin Foundation, has won the...
      Lupin concludes third edition of medical symposiums for Indian urology community

      Lupin concludes third edition of medical symposiums for Indian urology community

      Medical Dialogues Bureau22 Jan 2020 12:50 PM IST
      Mumbai: Pharma major Lupin Limited (Lupin) recently announced that it has successfully concluded the third edition of its series of medical symposiums...
      Glenmark offloads Indian gynaecology business for Rs 115 crore

      Glenmark offloads Indian gynaecology business for Rs 115 crore

      Medical Dialogues Bureau22 Jan 2020 11:39 AM IST
      New Delhi: In an attempt to drag down the financial burden, drug giant Glenmark Pharmaceuticals Limited (Glenmark) recently sold off...
      Novartis blockbuster Mayzent wins European nod for multiple sclerosis

      Novartis blockbuster Mayzent wins European nod for multiple sclerosis

      Medical Dialogues Bureau22 Jan 2020 11:25 AM IST
      The European marketing authorization makes Mayzent the first and only indicated oral treatment proven in SPMS patients with the active disease based...
      EC approves Roches Polivy combo in patients with previously treated aggressive lymphoma

      EC approves Roche's Polivy combo in patients with previously treated aggressive lymphoma

      Medical Dialogues Bureau22 Jan 2020 11:01 AM IST
      Roche announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in combination with...
      Horizon thyroid eye disease drug Tepezza priced at USD 14900 per vial

      Horizon thyroid eye disease drug Tepezza priced at USD 14900 per vial

      Medical Dialogues Bureau22 Jan 2020 10:06 AM IST
      Horizon said the drug, Tepezza will earn about $105 million in milestone payments in the first half of 2020. The company last week raised its...
      Zydus, China Medical System enter licensing agreement for desidustat

      Zydus, China Medical System enter licensing agreement for desidustat

      Medical Dialogues Bureau21 Jan 2020 3:15 PM IST
      Under the license agreement, CMS will pay Zydus an initial upfront payment, regulatory milestones, sales milestones and royalties on net sales of the...
      Alembic Pharma gets two USFDA observations for Karkhadi facility

      Alembic Pharma gets two USFDA observations for Karkhadi facility

      Medical Dialogues Bureau21 Jan 2020 12:50 PM IST
      New Delhi: Drugs maker, Alembic Pharma recently announced that the company's API facility located at Karkhadi has received Form 483 with two...
      Strides Pharma arm gets EIR from USFDA for Florida facility

      Strides Pharma arm gets EIR from USFDA for Florida facility

      Medical Dialogues Bureau21 Jan 2020 11:28 AM IST
      The Florida facility is one of the very few manufacturing facilities in the US with a soft gel capsule (SGC) manufacturing suite for formulations...
      Google CEO Sundar Pichai calls for regulation of AI

      Google CEO Sundar Pichai calls for regulation of AI

      Medical Dialogues Bureau21 Jan 2020 11:15 AM IST
      In 2018, Google pledged not to use AI in applications related to weapons, surveillance that violates international norms, or that works in ways that...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok